Abstract:An increasing interest in patient-specific disease modeling of neuropsychiatric disorders with multifactorial etiology has been witnessed by researchers worldwide [1]. Bipolar disorder (BD) is a complex neuropsychiatric disorder with high heritability rates that could benefit from the use of patient-specific cell lines to study molecular mechanisms [2]. We therefore read with interest the work of Hewitt and colleagues (2023), which investigated aspects of BD pathophysiology and more specifically calcium-related mechanisms, using induced pluripotent stem cells (iPSC)-derived neurons. However, we noted that some aspects of the study could be further clarified, which would facilitate the interpretation of these findings for the wider clinical and non-clinical scientific community interested in this field. For example, the absence of information regarding quality control (QC) in some of the generated iPSC lines, clinical details, repository information, and methodological details. The current study from Hewitt and colleagues (Suppl. Fig. S1 A) examined three patients and three controls (one clone each) [3]. However, it is concerning that neither the current study [3] nor the linked work by Zimmermann et al. [4] and Bavamian et al. [5] appeared to clearly provide and/or describe QC information for all the iPSCs that were produced [6]. Good Cell Culture Practices outlined by the International Society for Stem Cell Research highlights the need for structured iPSC generation and reporting, to enable information interchange and biological characterization of cell lines in a reproducible manner [7]. One of the international registries for pluripotent stem cells is the hPSCReg, which is free of charge and contains data about multiple cell lines generated by researchers around the world [8]. This possibility helps with the dissemination of trustworthy, reproducible information about newly generated iPSCs amongst the iPSC community. Using these cells for the examination of complex neuropsychiatric disorders is powerful, as the presence of numerous sporadic cases can be attributed to polygenic factors with individually small impact magnitudes, rather than solely to the impact of environmental factors or new mutations with larger effect sizes [9]. Therefore, it is crucial to thoroughly analyze clinical and polygenic data from the donors in order to assess the impact of environmental and genetic factors on the etiology of these disorders in sporadic cases [6]. Unfortunately, the article lacked the aforementioned data.

HiPSC-derived 3D neural models reveal neurodevelopmental pathomechanisms of the Cockayne Syndrome B

Cockayne Syndrome Patient iPSC-Derived Brain Organoids and Neurospheres Show Early Transcriptional Dysregulation of Biological Processes Associated with Brain Development and Metabolism

Perspectives in the investigation of Cockayne syndrome group B neurological disease: the utility of patient-derived brain organoid models

Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

Dysregulation of gene expression as a cause of Cockayne syndrome neurological disease

Deregulation of Neuro-Developmental Genes and Primary Cilium Cytoskeleton Anomalies in iPSC Retinal Sheets from Human Syndromic Ciliopathies

Rescue of Premature Aging Defects in Cockayne Syndrome Stem Cells by CRISPR/Cas9-mediated Gene Correction

Autophagy pathway upregulation in a human iPSC-derived neuronal model of Cohen syndrome with VPS13B missense mutations

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: from 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Human iPSC-Derived Neuronal Cells From CTBP1-Mutated Patients Reveal Altered Expression of Neurodevelopmental Gene Networks

Modeling primary microcephaly with human brain organoids reveals fundamental roles of CIT kinase activity

Modeling Cortical Versus Hippocampal Network Dysfunction in a Human Brain Assembloid Model of Epilepsy and Intellectual Disability

iPSC-derived models of PACS1 syndrome reveal transcriptional and functional deficits in neuron activity

DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome

General loss of proteostasis links Huntington disease to Cockayne syndrome

A novel iPSC model of Bryant-Li-Bhoj neurodevelopmental syndrome demonstrates the role of histone H3.3 in neuronal differentiation and maturation

Joubert syndrome-derived induced pluripotent stem cells show altered neuronal differentiation in vitro

Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons

Early Developmental Origins of Cortical Disorders Modeled in Human Neural Stem Cells

Correspondence to "Bipolar disorder-iPSC derived neural progenitor cells exhibit dysregulation of store-operated Ca 2+ entry and accelerated differentiation" by Hewitt et al. (PMID: 37402854)

Altered neuronal migratory trajectories in human cerebral organoids derived from individuals with neuronal heterotopia